About Bosnalife
Bosnalife is a Healthcare company based in Hyderabad (India) founded in 2023. It provides end-to-end drug development, manufacturing, and research services for biotech firms. It operates on a B2B model. The company has 1 employees. Its Indian entity Sambi Life Sciences Private Limited reported revenue of ₹94.8 Lakh. Bosnalife offers products and services including Process Development, Manufacturing Services, Amidites, Galnac Derivatives, and Sugar Derivatives. Its focus areas include Pharmaceuticals, Drug Manufacturing, API Production and Biotechnology.
Company details
Bosna Sciences, along with Bosna Pharma, is a full-service CRO and CDMO organization based in Hyderabad, India. They deliver end-to-end services from pre-clinical drug substance development to commercial manufacturing, using advanced technologies like Amidites and Galnac derivatives. The company works with global biotech and pharma clients to accelerate drug discovery from concept to commercialization, emphasizing sustainable innovation, ethical practices, and a self-reliant supply chain for timely, quality products.
- Headquarters Hyderabad, India
- Employees 1
- SectorsHealthcare
- Website bosnalife.com
- Legal Name Sambi Life Sciences Private Limited
- Date of Incorporation 19 Jan, 2021
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹94.8 Lakh
FY 2024 · +1009% YoY
- Net Loss-₹37,320
FY 2024 · 0% margin
- EBITDA₹29.9 Lakh
FY 2024 · 32% margin
- Employee Count1
Associated legal entities of Bosnalife
Bosnalife operates through Sambi Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sambi Life Sciences Private Limited CIN U24290TG2021PTC147862 | Active | 19 Jan 2021 | Hyderabad, Telangana | ₹0.9 Cr | 5 | View details |
Products & Services of Bosnalife
Bosnalife offers a comprehensive portfolio of products and services, including Process Development, Manufacturing Services, Amidites, Galnac Derivatives, and Sugar Derivatives.
Rapid development of scalable chemical processes for drug manufacturing.
High-quality API and intermediates production for pharma clients.
Advanced solutions for innovative drug development applications.
Specialized derivatives for enhanced drug manufacturing processes.
Sustainable intermediates used in pharmaceutical production.
High-quality peptides for drug discovery and development.
Board of directors of Sambi Life Sciences Private Limited (Bosnalife)
Sambi Life Sciences Private Limited is the primary company behind Bosnalife. The board of Sambi Life Sciences Private Limited currently have 5 directors; the longest-serving is Madhavi Reddy Sambireddy, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Madhavi Reddy Sambireddy DIN 02584592 | Director | 19 Jan 2021 | 5 yrs 9 mo | Sambi Life Sciences Private Limited |
| Krishnareddy Sambireddy DIN 03210173 | Director | 19 Jan 2021 | 5 yrs 9 mo | Sambi Life Sciences Private Limited |
| Sandesh Reddy Korandla DIN 08424926 | Director | 19 Jan 2021 | 5 yrs 9 mo | Sambi Life Sciences Private Limited |
| Hanmanth Pradeep Reddy DIN 08424925 | Director | 19 Jan 2021 | 5 yrs 9 mo | Sambi Life Sciences Private Limited |
| Venkat Narsimhareddy Sambi DIN 01629711 | Director | 19 Jan 2021 | 5 yrs 9 mo | Sambi Life Sciences Private Limited |
Financials of Bosnalife
Figures of Sambi Life Sciences Private Limited, the primary company behind Bosnalife, for FY 2024. Revenue was ₹94.8 Lakh (+1009% year on year). Net loss was -₹37,320 (0% margin). EBITDA was ₹29.9 Lakh (32% margin).
- ₹94.8 LakhRevenue · FY 2024 · +1009% YoY
- -₹37,320Net loss · 0% margin
- ₹29.9 LakhEBITDA · 32% margin
- ₹61 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Sambi Life Sciences Private Limited are on its company page.
Detailed financial statements for Bosnalife
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bosnalife
Bosnalife was founded in 2023.
Bosnalife is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Bosnalife has 1 employees.
The primary company behind Bosnalife, Sambi Life Sciences Private Limited, reported revenue of ₹94.8 Lakh for FY 2024, up 1009% year on year.
Bosna Sciences, along with Bosna Pharma, is a full-service CRO and CDMO organization based in Hyderabad, India. They deliver end-to-end services from pre-clinical drug substance development to commercial manufacturing, using advanced technologies like Amidites and Galnac derivatives. The company works with global biotech and pharma clients to accelerate drug discovery from concept to commercialization, emphasizing sustainable innovation, ethical practices, and a self-reliant supply chain for timely, quality products.
Bosnalife offers Process Development, Manufacturing Services, Amidites, Galnac Derivatives, and 2 more products and services.
Bosnalife operates through Sambi Life Sciences Private Limited.
The legal entities of Bosnalife currently have 5 directors, including Madhavi Reddy Sambireddy, Krishnareddy Sambireddy, Sandesh Reddy Korandla and others.